Retrieve available abstracts of 36 articles: HTML format
Single Articles
May 2025
BIAGETTI B, Cordero Asanza E, Perez-Lopez C, Araujo-Castro M, et al Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish
Observational Multicenter Study.
J Clin Endocrinol Metab. 2025;110:e1811-e1820. PubMedAbstract available
LV Z, Fu Y, Ma Y, Liu C, et al Associations Between Visceral and Liver Fat and Cardiac Structure and Function: A
UK Biobank Study.
J Clin Endocrinol Metab. 2025;110:e1856-e1865. PubMedAbstract available
April 2025
ZHENG X, Zhao D, Wang L, Wang Y, et al Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and
Cardiometabolic Risk Factor in US Adolescents.
J Clin Endocrinol Metab. 2025;110:e1458-e1465. PubMedAbstract available
LIAO Z, Wang J, Chen Y, Li W, et al Associations of Body Mass Index Growth Rates and Body Composition With
Cardiometabolic Risks in Chinese Preschool Children.
J Clin Endocrinol Metab. 2025;110:e1439-e1450. PubMedAbstract available
LOH WJ, Chan DC, Pang J, Hooper AJ, et al Opportunistic Detection of Phytosterolemia During Genetic Testing for FH: Case
Series and Contextual Review.
J Clin Endocrinol Metab. 2025;110:1358-1364. PubMedAbstract available
March 2025
SPAGNUOLO CM, Wang J, McIntyre AD, Kennedy BA, et al Comparison of Patients With Familial Chylomicronemia Syndrome and Multifactorial
Chylomicronemia Syndrome.
J Clin Endocrinol Metab. 2025;110:1158-1165. PubMedAbstract available
CHEN LM, Valentine A, Davis SM, Graber E, et al Multicenter Analysis of Cardiometabolic-Related Diagnoses in Youth With
Congenital Adrenal Hyperplasia: A PEDSnet Study.
J Clin Endocrinol Metab. 2025;110:e1009-e1016. PubMedAbstract available
February 2025
TRICO D, Rebelos E, Astiarraga B, Baldi S, et al Effects of Hypertriglyceridemia With or Without NEFA Elevation on beta-cell Function
and Insulin Clearance and Sensitivity.
J Clin Endocrinol Metab. 2025;110:e667-e674. PubMedAbstract available
PAQUETTE M, Trinder M, Guay SP, Brunham LR, et al Prevalence of Dysbetalipoproteinemia in the UK Biobank According to Different
Diagnostic Criteria.
J Clin Endocrinol Metab. 2025;110:e703-e709. PubMedAbstract available
January 2025
CLAAHSEN-VAN DER GRINTEN HL, Adriaansen BPH, Falhammar H Challenges in Adolescent and Adult Males With Classic Congenital Adrenal
Hyperplasia Due to 21-Hydroxylase Deficiency.
J Clin Endocrinol Metab. 2025;110. PubMedAbstract available
KIM S, Subramanian S Approach to Lipid Management in the Patient with Diabetes.
J Clin Endocrinol Metab. 2025 Jan 11:dgaf018. doi: 10.1210. PubMedAbstract available
December 2024
BOLLIG KJ, Barnhart KT, Schisterman EF, Johnstone EB, et al The Association of Female and Male Preconception Dyslipidemia With Live Birth in
Couples Seeking Fertility Treatment.
J Clin Endocrinol Metab. 2024;110:91-101. PubMedAbstract available
TAVAGLIONE F, Marafioti G, Romeo S, Jamialahmadi O, et al Machine Learning Reveals the Contribution of Lipoproteins to Liver Triglyceride
Content and Inflammation.
J Clin Endocrinol Metab. 2024;110:218-227. PubMedAbstract available
BARETELLA O, Blum MR, Abolhassani N, Alwan H, et al Associations between subclinical thyroid dysfunction and cardiovascular risk
factors according to age and sex.
J Clin Endocrinol Metab. 2024 Dec 12:dgae860. doi: 10.1210. PubMedAbstract available
November 2024
GUAY SP, Paquette M, Blais C, Fortin A, et al High hsCRP Concentration Is Associated With Acute Pancreatitis in Multifactorial
Chylomicronemia Syndrome.
J Clin Endocrinol Metab. 2024;109:e2255-e2260. PubMedAbstract available
October 2024
DAIANA I, Didac L, Celia RB, Natalia A, et al The Lipoprotein Profile Evaluated by 1H-NMR Improves the Performance of Genetic
Testing in Familial Hypercholesterolemia.
J Clin Endocrinol Metab. 2024;109:e2090-e2099. PubMedAbstract available
September 2024
MARCHESAN LB, da Silva TR, Spritzer PM Topiramate added to metformin for obesity control in women with polycystic ovary
syndrome: a randomized clinical trial.
J Clin Endocrinol Metab. 2024 Sep 14:dgae637. doi: 10.1210. PubMedAbstract available
PAQUETTE M, Trinder M, Guay SP, Brunham LR, et al Predictors of cardiovascular disease in individuals with dysbetalipoproteinemia:
a prospective study in the UK Biobank.
J Clin Endocrinol Metab. 2024 Sep 7:dgae618. doi: 10.1210. PubMedAbstract available
August 2024
YANG C, Ji L, Han X Low C reactive protein-alleles in hepatocyte nuclear factor 1A are associated
with an increased risk of cardiovascular disease: a Meta-analysis.
J Clin Endocrinol Metab. 2024 Aug 30:dgae602. doi: 10.1210. PubMedAbstract available
July 2024
ZHAI X, Li Y, Teng X, Teng W, et al Relationship Between Serum Thyrotropin Levels and Metabolic Diseases in Older
Adults.
J Clin Endocrinol Metab. 2024 Jul 2:dgae387. doi: 10.1210. PubMedAbstract available
June 2024
SANTOS RD Elevated Lipoprotein(a) and Its Implications for Familial Hypercholesterolemia
Diagnosis, Prognosis, and Family Screening.
J Clin Endocrinol Metab. 2024;109:e1544-e1545. PubMed
AGBAJE AO Associations of Sedentary Time and Physical Activity From Childhood With Lipids:
A 13-Year Mediation and Temporal Study.
J Clin Endocrinol Metab. 2024;109:e1494-e1505. PubMedAbstract available
February 2024
MAGNO S, Ceccarini G, Corvillo F, Pelosini C, et al Clinical Characteristics of Patients With Acquired Partial Lipodystrophy: A
Multicenter Retrospective Study.
J Clin Endocrinol Metab. 2024;109:e932-e944. PubMedAbstract available
HEDEGAARD BS, Nordestgaard BG, Kanstrup HL, Thomsen KK, et al High Lipoprotein(a) May Explain One-Quarter of Clinical Familial
Hypercholesterolemia Diagnoses in Danish Lipid Clinics.
J Clin Endocrinol Metab. 2024;109:659-667. PubMedAbstract available
BESCI O, Foss de Freitas MC, Guidorizzi NR, Guler MC, et al Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of
115 Cases and a Systematic Review.
J Clin Endocrinol Metab. 2024;109:e1204-e1224. PubMedAbstract available
U-DIN M, Ahmed BA, Syed SA, Ong FJ, et al Characteristics of Abdominal Visceral Adipose Tissue, Metabolic Health and the
Gut Microbiome in Adults.
J Clin Endocrinol Metab. 2024;109:680-690. PubMedAbstract available
January 2024
PARK SY, Jun JE, Jeong IK, Ahn KJ, et al Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity
Statin Monotherapy in Type 2 Diabetes.
J Clin Endocrinol Metab. 2024 Jan 4:dgad714. doi: 10.1210. PubMedAbstract available
December 2023
ALVAREZ-JIMENEZ L, Morales-Palomo F, Moreno-Cabanas A, Ortega JF, et al Acute Statin Withdrawal Does not Interfere With the Improvements of a Session of
Exercise in Postprandial Metabolism.
J Clin Endocrinol Metab. 2023;109:80-91. PubMedAbstract available
November 2023
LI S, Cui M, Liu Y, Liu X, et al Metabolic profiles of type 2 diabetes and their association with renal
complications.
J Clin Endocrinol Metab. 2023 Nov 2:dgad643. doi: 10.1210. PubMedAbstract available
October 2023
HIRSCHBERG AL Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What
Is the Evidence?
J Clin Endocrinol Metab. 2023 Oct 27:dgad590. doi: 10.1210. PubMedAbstract available
September 2023
MEYER EJ, Wittert GA Approach the patient with obstructive sleep apnea and obesity.
J Clin Endocrinol Metab. 2023 Sep 27:dgad572. doi: 10.1210. PubMedAbstract available
TAO X, Liu L, Ma P, Hu J, et al Association of Circulating Very Long Chain Saturated Fatty Acids with
Cardiovascular Mortality in NHANES 2015-2016.
J Clin Endocrinol Metab. 2023 Sep 21:dgad561. doi: 10.1210. PubMedAbstract available
July 2023
CHEN JX, Geng T, Zhang YB, Wang Y, et al Associations of Clinical Risk Factors and Novel Biomarkers with Age at Onset of
Type 2 Diabetes.
J Clin Endocrinol Metab. 2023 Jul 15:dgad422. doi: 10.1210. PubMedAbstract available
May 2023
GRIGORYAN S, Nhan W, Zhang L, Urban C, et al Rates of Pheochromocytoma/Paraganglioma Screening in At-Risk Populations.
J Clin Endocrinol Metab. 2023;108:e343-e349. PubMedAbstract available
April 2023
SYED-ABDUL MM, Stahel P, Zembroski A, Tian L, et al Glucagon-like Peptide-2 Acutely Enhances Chylomicron Secretion in Humans Without
Mobilizing Cytoplasmic Lipid Droplets.
J Clin Endocrinol Metab. 2023;108:1084-1092. PubMedAbstract available
March 2023
NEWMAN CB, Tobert JA Targeting PCSK9 With Antibodies and Gene Silencing to Reduce LDL Cholesterol.
J Clin Endocrinol Metab. 2023;108:784-790. PubMedAbstract available